Keywords: ایمونوتراپی; Mitoxantrone; Vaccination; Immunogenic cell death; Colon cancer; Liver metastases; T cells; Immunotherapy; Tumor-infiltrating lymphocytes;
مقالات ISI ایمونوتراپی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمونوتراپی; drug reaction; gp100; granuloma; granulomatous reaction; immunotherapy; interleukin-2; melanoma; melanoma-associated antigen 3; resiquimod; IL-2; interleukin-2 (); MAGE-3; melanoma-associated antigen 3 ();
Keywords: ایمونوتراپی; Immunotherapy; Tumor infiltrating lymphocytes; Antigen; Immune checkpoint inhibitor; Vaccine; Type I T-cells;
Keywords: ایمونوتراپی; Immunotherapy; Lynch syndrome; Mismatch repair; PD-1 inhibitors;
Keywords: ایمونوتراپی; AE; autoimmune epilepsy; AED; antiepileptic drug; IMT; immunotherapy; CBZ; carbamazepine; LCM; lacosamide; LTG; lamotrigine; LEV; levetiracetam; OXZ; oxcarbazepine; PHT; phenytoin; Autoimmune epilepsy;
Keywords: ایمونوتراپی; Immunotherapy; Programmed cell death 1 receptor; Programmed cell death 1 ligand; Reinduction; Long-term follow-up;
Keywords: ایمونوتراپی; BM; brain metastasis; AE; adverse event; CI; confidence interval; CTLA4; cytotoxic T-lymphocyte antigen-4; CT; computed-tomography; GPA; Graded Prognostic Assessment score; IORR; intracerebral objective response rate; IQR; interquartile range; NSCLC; nonâ
Keywords: ایمونوتراپی; Sarcoma; Immunotherapy; Epigenetics; Mutational burden; Chemoresistance;
Keywords: ایمونوتراپی; Multiple primary tumors; Next-generation sequencing; Tumor mutational burden; Immunotherapy;
Keywords: ایمونوتراپی; Anaphylaxis; immunotherapy; peanut allergy; pediatrics;
Keywords: ایمونوتراپی; Allergic conjunctivitis; Immunotherapy; Oral tolerance; Pollen; Transgenic rice;
Keywords: ایمونوتراپی; Pancreatic cancer; Immunotherapy; Dendritic cells;
Keywords: ایمونوتراپی; TKI; Angiogenesis; Immune system; Renal carcinoma; Immunotherapy;
Keywords: ایمونوتراپی; Anti-PD-1/PD-L1; Immunotherapy; Immune checkpoint inhibitors; mRCC; Targeted therapies;
Keywords: ایمونوتراپی; Immunotherapy; Organ transplant; Allograft; Immune checkpoint; Checkpoint inhibitor;
Keywords: ایمونوتراپی; Urothelial carcinoma; Bladder cancer; Immunotherapy; Checkpoint inhibitors; Chemotherapy; Clinical trials; Targeted therapy; Platinum ineligible;
Keywords: ایمونوتراپی; Bladder cancer; Immunotherapy; Prostate cancer; Renal cancer; Telomerases;
Keywords: ایمونوتراپی; Bladder cancer; Cost-effectiveness; Immunotherapy; Programmed death 1 receptor; Transitional cell carcinoma;
Keywords: ایمونوتراپی; Atezolizumab; Immunotherapy; Number of prior regimens; Previous platinum-based chemotherapy; Urothelial carcinoma;
Keywords: ایمونوتراپی; Cost Effectiveness; Everolimus; Immunotherapy; Programmed death 1 receptor; Renal cell carcinoma;
Keywords: ایمونوتراپی; Angiogenesis; cancer; cancer stem-cell; check-point; immunotherapy; inflammation; metastasis; oncogene; tumour-suppressor gene;
Keywords: ایمونوتراپی; Immunotherapy; Combination therapy; Review; Triple negative breast cancer;
Keywords: ایمونوتراپی; Atezolizumab; Expanded access program; Immunotherapy; Urothelial carcinoma;
Keywords: ایمونوتراپی; Colorectal cancer; Cytokines; Immune response; Immunotherapy; Inflammation; Anatomical subsite heterogeneity; CIMP; CpG island methylator phenotype; CIN; chromosomal instability; CRC; colorectal cancer; FGF-2; fibroblast growth factor 2 (basic); G-CSF; gr
Keywords: ایمونوتراپی; Sarcomatoid renal cell carcinoma; Renal cell carcinoma; Nephrectomy; Chemotherapy; Targeted therapy; Immunotherapy;
Keywords: ایمونوتراپی; Bayesian Markov model; Cost-effectiveness; First-line therapy; Immunotherapy; NSCLC; Pembrolizumab;
Keywords: ایمونوتراپی; Lung cancer; Latin America; Immunotherapy; Targeted therapy; Healthcare access;
Keywords: ایمونوتراپی; EBV; Immunotherapy; PD-L1; Gastric cancer; Viruses; Biomarker;
Keywords: ایمونوتراپی; Irinotecan; Oxaliplatin; 5-fluorouracil; Antiepidermal growth factor receptor antibody; Vascular endothelial growth factor antibody; Immunotherapy; Regorafenib; Trifluridine/tipiracil;
Keywords: ایمونوتراپی; Animal models; Cancer microenvironment; Immuno-oncology; Immunotherapy; One Health;
Keywords: ایمونوتراپی; CAF; cancer-associated fibroblast; CRC; colorectal cancer; FAP; fibroblast activation protein; H&E; hematoxylin-and-eosin; HGP; histopathological growth pattern; LSEC; liver sinusoidal endothelial cells; OS; overall survival; VEGF; vascular endothelial gr
Keywords: ایمونوتراپی; Cancer; Transmissible venereal tumor; Tumor cell lysate; Dendritic cells; Immunotherapy;
Keywords: ایمونوتراپی; Hepatocellular carcinoma; Systemic treatment; Immunotherapy; Tyrosine kinase inhibitor;
Keywords: ایمونوتراپی; Microwave ablation; Immune checkpoints blockade; Breast cancer; Immunotherapy; T-cell;
Keywords: ایمونوتراپی; Immunotherapy; CAR-T; Cellular therapy; Toxicity;
Keywords: ایمونوتراپی; Adolescent and young adult; Acute lymphoblastic leukemia; Clinical trials; Immunotherapy; Salvage chemotherapy;
Keywords: ایمونوتراپی; Malignant pleural effusion; Intra-pleural bacterial products; Immunotherapy; Systematic review;
Keywords: ایمونوتراپی; Melanoma brain metastasis; Radiation therapy; Stereotactic radiosurgery; SRS; Immunotherapy; NCDB;
Keywords: ایمونوتراپی; Moxibustion; Tuberculosis; HIV; MDR-TB; Immuno-modulation; Immunotherapy; Randomised control trial;
Keywords: ایمونوتراپی; Adenosine; gastric cancer; A2aR signaling; immunotherapy;
Keywords: ایمونوتراپی; cancer; immune-related adverse event; immunotherapy; primary care; toxicities;
Keywords: ایمونوتراپی; Prostate cancer; kidney cancer; bladder cancer; chemotherapy; immunotherapy;
Keywords: ایمونوتراپی; Glioblastoma; Immunotherapy; Adoptive transfer; Immunization; Passive; Cancer vaccines;
Keywords: ایمونوتراپی; Status epilepticus; Inflammatory CNS disease; Autoimmune encephalitis; Immunotherapy; Unknown/cryptogenic; CNS; central nervous system; SE; status epilepticus; ICU; intensive care unit; NORSE; new onset refractory status epilepticus; EEG; electroencephalo
Keywords: ایمونوتراپی; VC; verrucous carcinoma; BSCC; basaloid squamous cell carcinoma; LEC; lymphoepithelial carcinoma; ASC; adenosquamous carcinoma; SCNC; small cell neuroendocrine carcinoma; LCNC; large cell neuroendocrine carcinoma; NUTMC; NUT midline carcinoma; RMS; rhabdo
Keywords: ایمونوتراپی; Cancer; Immunotherapy; Checkpoint modulators; Cancer vaccines; Adoptive immunotherapy; CAR-T; Immune-related adverse events; Oncologic emergency;
Keywords: ایمونوتراپی; Allergen-specific IgE; Allergoid; Cat dander; Immunotherapy; Safety;
Keywords: ایمونوتراپی; Alloantigen; Cyclophosphamide; Immunotherapy; Regulatory T cells; Tumor microenvironment;
Keywords: ایمونوتراپی; Inflammation; Immunomodulation; Immunotherapy; Prevention; Immune mechanisms of cardiovascular disease; Ischemic heart disease;
Keywords: ایمونوتراپی; Atezolizumab; Chemotherapy; Immunotherapy; Non-small-cell lung cancer; Chemotherapy-immunotherapy combinations;